EARNEST PARTNERS LLC 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-10 10:22 am Sale |
2022-07-31 | 13G | Meridian Bioscience, Inc. VIVO |
EARNEST PARTNERS LLC | 138,110 0.300% |
-3,586,200 (-96.29%) |
Filing |
| 2022-02-10 08:53 am Sale |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
EARNEST PARTNERS LLC | 3,724,310 8.600% |
-617,524 (-14.22%) |
Filing |
| 2021-04-12 4:56 pm Purchase |
2021-03-31 | 13G | Meridian Bioscience, Inc. VIVO |
EARNEST PARTNERS LLC | 4,341,834 10.100% |
4,341,834 (New Position) |
Filing |